Serum exosomal microRNAs as predictive markers for EGFR mutations in non–small‐cell lung cancer

Abstract

The exosomal miR-1169 and miR-260 as potential candidates, which contain specific characteristics that can distinguish between wild-type EGFR and mutant EGFR NSCLC patients in early-stage cancers.